Article Details

mAbxience Announces European Commission Approval of Denosumab Biosimilars

Retrieved on: 2025-07-02 15:12:06

Tags for this article:

Click the tags to see associated articles and topics

mAbxience Announces European Commission Approval of Denosumab Biosimilars. View article details on hiswai:

Excerpt

Denosumab is a human monoclonal antibody that works by inhibiting the receptor activator of nuclear factor kappa-B ligand (RANKL), thereby ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo